Baldwin Brothers LLC Gilead Sciences, Inc. Transaction History

Baldwin Brothers LLC

  • $1.43 Billion
  • Q3 2024

A detailed history of Baldwin Brothers LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Baldwin Brothers LLC holds 304 shares of GILD stock, worth $27,417. This represents 0.0% of its overall portfolio holdings.

Number of Shares
304
Previous 271 12.18%
Holding current value
$27,417
Previous $18,000 38.89%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
BUY
$66.59 - $83.99 $2,197 - $2,771
33 Added 12.18%
304 $25,000
Q2 2024

Jul 12, 2024
SELL
$63.15 - $72.88 $410,727 - $474,011
-6,504 Reduced 96.0%
271 $18,000
Q1 2024

Apr 12, 2024
SELL
$71.58 - $87.29 $634,771 - $774,087
-8,868 Reduced 56.69%
6,775 $496,000
Q4 2023

Jan 08, 2024
SELL
$73.27 - $83.09 $1.21 Million - $1.37 Million
-16,507 Reduced 51.34%
15,643 $1.27 Million
Q3 2023

Oct 10, 2023
SELL
$73.94 - $80.67 $66,176 - $72,199
-895 Reduced 2.71%
32,150 $2.41 Million
Q2 2023

Jul 14, 2023
SELL
$76.01 - $86.7 $155,212 - $177,041
-2,042 Reduced 5.82%
33,045 $2.55 Million
Q1 2023

Apr 21, 2023
SELL
$77.31 - $88.08 $24,584 - $28,009
-318 Reduced 0.9%
35,087 $2.91 Million
Q4 2022

Jan 27, 2023
BUY
$62.32 - $89.47 $2.19 Million - $3.15 Million
35,162 Added 14469.96%
35,405 $0
Q2 2022

Jul 18, 2022
SELL
$57.72 - $65.01 $865 - $975
-15 Reduced 5.81%
243 $15,000
Q1 2022

Apr 13, 2022
BUY
$57.92 - $72.58 $405 - $508
7 Added 2.79%
258 $15,000
Q1 2021

Apr 08, 2021
SELL
$60.0 - $68.46 $6,000 - $6,845
-100 Reduced 28.49%
251 $16,000
Q1 2020

Apr 15, 2020
BUY
$62.63 - $80.22 $8,517 - $10,909
136 Added 63.26%
351 $26,000
Q4 2019

Jan 29, 2020
SELL
$61.62 - $67.78 $8,811 - $9,692
-143 Reduced 39.94%
215 $14,000
Q3 2019

Oct 10, 2019
SELL
$62.51 - $69.0 $4,375 - $4,830
-70 Reduced 16.36%
358 $23,000
Q2 2019

Jul 19, 2019
SELL
$61.87 - $69.38 $1,237 - $1,387
-20 Reduced 4.46%
428 $29,000
Q1 2019

Apr 24, 2019
SELL
$62.53 - $70.05 $22,510 - $25,218
-360 Reduced 44.55%
448 $29,000
Q4 2018

Feb 01, 2019
BUY
$60.54 - $79.0 $15,679 - $20,461
259 Added 47.18%
808 $51,000
Q3 2018

Oct 26, 2018
SELL
$71.28 - $78.92 $4,989 - $5,524
-70 Reduced 11.31%
549 $42,000
Q2 2018

Jul 24, 2018
BUY
$64.88 - $75.68 $6,488 - $7,568
100 Added 19.27%
619 $44,000
Q1 2018

Apr 16, 2018
BUY
$72.84 - $88.8 $8,813 - $10,744
121 Added 30.4%
519 $39,000
Q4 2017

Jan 24, 2018
BUY
$71.15 - $83.52 $8,395 - $9,855
118 Added 42.14%
398 $29,000
Q3 2017

Oct 26, 2017
BUY
$72.11 - $85.47 $20,190 - $23,931
280
280 $23,000

Others Institutions Holding GILD

# of Institutions
1,923
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Baldwin Brothers LLC Portfolio

Follow Baldwin Brothers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email